IDXG 0.85 (-68.52%)
US46062X3035Medical Diagnostics & ResearchDiagnostics & Research

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Performance 10 years - IDXG ranking 57 / 58

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.47K
3. Medpace Holdings MEDP
1.15K
4. Natera NTRA
872.22
5. RadNet RDNT
724.7
6. IDEXX Laboratories IDXX
455.77
7. DexCom DXCM
432.24
8. Thermo Fisher Scientific TMO
316.81
9. Danaher DHR
311.25
10. Mettler-Toledo MTD
304.11
11. Icon ICLR
301.14
12. NeoGenomics NEO
247.53
13. PerkinElmer PKI
247.07
14. IQVIA Holdings IQV
244.18
15. Agilent Technologies A
238.51
16. Twist Bioscience TWST
235.38
17. Waters WAT
225.59
18. CareDx CDNA
215.07
19. Charles River Laboratories CRL
173.42
20. Laboratory Corp of America Holdings LH
130.55
21. Quest Diagnostics DGX
120.95
22. Syneos Health SYNH
113.83
23. Fulgent Genetics FLGT
98.81
24. Inotiv NOTV
95.96
25. Exact Sciences EXAS
94.83
26. Qiagen QGEN
86.31
27. Meridian Bioscience VIVO
60.69
28. Guardant Health GH
32.29
29. National Research NRC
27.2
30. Ortho Clinical Diagnostics Holdings OCDX
13.74
31. Anixa Biosciences ANIX
-18.18
32. Olink Holding OLK
-26.82
33. Illumina ILMN
-28.28
34. Neogen NEOG
-32.56
35. Bioventus BVS
-38.54
36. Sotera Health SHC
-51.44
37. Sera Prognostics SERA
-53.83
38. Myriad Genetics MYGN
-61.18
39. Global Cord Blood CO
-66.57
40. Pacific Biosciences of California PACB
-72.94
41. MaxCyte MXCT
-74.1
42. DarioHealth DRIO
-75.47
43. Personalis PSNL
-76.31
44. Enzo Biochem ENZ
-77.8
45. Exagen XGN
-81.13
46. Co-Diagnostics CODX
-83.5
47. MDxHealth MDXH
-83.7
48. Psychemedics PMD
-86
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-90.65
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.46
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.9
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.49
58. Precipio PRPO
-99.77

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.